User contributions
Jump to navigation
Jump to search
- 22:52, 6 December 2022 diff hist +4 m Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 16:30, 6 December 2022 diff hist +104 Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 16:26, 6 December 2022 diff hist +1,708 Melanoma →Neoadjuvant response criteria
- 14:12, 3 August 2022 diff hist +38 m User:Ryannguyen personal page update current Tag: visualeditor
- 15:23, 3 April 2022 diff hist +359 Melanoma →Nivolumab & Relatlimab {{#subobject:6abj1d|Regimen=1}}
- 15:19, 3 April 2022 diff hist +539 Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 01:30, 30 January 2022 diff hist +1 m Melanoma →Ipilimumab & Nivolumab {{#subobject:51gu10|Regimen=1}}
- 02:58, 28 January 2022 diff hist +1,886 Melanoma, BRAF-mutated →Advanced or metastatic disease, BRAF inhibitor-naive
- 02:39, 28 January 2022 diff hist +2,493 Uveal melanoma →Metastatic or unresectable disease
- 02:21, 28 January 2022 diff hist +116 Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 02:16, 28 January 2022 diff hist +644 Melanoma →References
- 02:14, 28 January 2022 diff hist +1,590 Melanoma →Metastatic or unresectable disease, second-line
- 02:01, 28 January 2022 diff hist +1,449 Melanoma →Metastatic or unresectable disease, first-line
- 02:08, 11 July 2021 diff hist +1,489 Esophageal squamous cell carcinoma →Metastatic or locally advanced disease, first-line
- 01:55, 11 July 2021 diff hist +44 Esophageal squamous cell carcinoma →Ipilimumab & Nivolumab {{#subobject:62bagc|Regimen=1}}
- 01:46, 11 July 2021 diff hist 0 m Esophageal squamous cell carcinoma →Cisplatin, Paclitaxel, Camrelizumab {{#subobject:5d50ee|Regimen=1}}
- 01:46, 11 July 2021 diff hist +117 Esophageal squamous cell carcinoma →Cisplatin & Paclitaxel {{#subobject:5d50ee|Regimen=1}}
- 01:44, 11 July 2021 diff hist +116 Esophageal squamous cell carcinoma →Cisplatin, Paclitaxel, Camrelizumab {{#subobject:5d50ee|Regimen=1}}
- 03:50, 26 April 2021 diff hist +3,695 Esophageal adenocarcinoma →Metastatic or locally advanced disease, first-line
- 03:09, 26 April 2021 diff hist +1,838 Colon cancer →Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy
- 22:54, 23 April 2021 diff hist +1,774 Colorectal cancer, HER2-positive →Advanced or metastatic disease, second or third-line therapy
- 20:14, 24 March 2021 diff hist 0 Esophageal cancer →Cisplatin & Paclitaxel {{#subobject:5d50ee|Regimen=1}}
- 20:13, 24 March 2021 diff hist 0 m Esophageal cancer →Cisplatin, Docetaxel, RT {{#subobject:21719f|Regimen=1}}
- 20:13, 24 March 2021 diff hist 0 Esophageal cancer →Fluorouracil, Oxaliplatin, RT {{#subobject:94b79a|Regimen=1}}
- 20:10, 24 March 2021 diff hist 0 Esophageal cancer →Cisplatin & Fluorouracil (CF) {{#subobject:37e6ba|Regimen=1}}
- 22:40, 22 March 2021 diff hist +1,268 Esophageal squamous cell carcinoma →Cisplatin, Fluorouracil, Cetuximab {{#subobject:717dc4|Regimen=1}}
- 22:40, 22 March 2021 diff hist -1,102 Esophageal cancer →Cisplatin & Paclitaxel {{#subobject:5d50ee|Regimen=1}}
- 22:37, 22 March 2021 diff hist +2,204 Esophageal squamous cell carcinoma →Definitive therapy
- 22:36, 22 March 2021 diff hist -1,936 Esophageal cancer →Cisplatin, Docetaxel, RT {{#subobject:21719f|Regimen=1}}
- 22:34, 22 March 2021 diff hist +2,102 Esophageal squamous cell carcinoma
- 22:34, 22 March 2021 diff hist -1,619 Esophageal cancer →Neoadjuvant chemoradiotherapy
- 22:23, 22 March 2021 diff hist -3,308 Esophageal cancer →Pembrolizumab monotherapy {{#subobject:c798a3|Regimen=1}}
- 22:22, 22 March 2021 diff hist -1,830 Esophageal cancer →Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}}
- 22:22, 22 March 2021 diff hist -957 Esophageal cancer →Regimen variant #2, 75 mg/m2, indefinite {{#subobject:abe193|Variant=1}}
- 22:22, 22 March 2021 diff hist -1,230 Esophageal cancer →Etoposide monotherapy {{#subobject:344c29|Regimen=1}}
- 22:21, 22 March 2021 diff hist -2,322 Esophageal cancer →Cisplatin, Fluorouracil, Cetuximab {{#subobject:717dc4|Regimen=1}}
- 22:20, 22 March 2021 diff hist -3,801 Esophageal cancer →Cisplatin & Fluorouracil (CF) {{#subobject:4d9936|Regimen=1}}
- 22:19, 22 March 2021 diff hist -1,617 Esophageal cancer →Cisplatin & Docetaxel {{#subobject:724868|Regimen=1}}
- 22:18, 22 March 2021 diff hist -1,855 Esophageal cancer →Fluorouracil & Paclitaxel {{#subobject:58ub68|Regimen=1}}
- 22:16, 22 March 2021 diff hist -2,096 Esophageal cancer →Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}}
- 22:12, 22 March 2021 diff hist -1,846 Esophageal cancer →Neoadjuvant induction therapy
- 22:10, 22 March 2021 diff hist +116 Esophageal cancer →Regimen {{#subobject:d18acj2|Variant=1}}
- 15:33, 17 March 2021 diff hist +47 Esophageal cancer
- 15:30, 17 March 2021 diff hist +23,324 N Esophageal squamous cell carcinoma Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Page editor''' ! col..."
- 01:22, 17 December 2020 diff hist -14 Esophageal cancer →Regimen {{#subobject:d18acj2|Variant=1}}
- 01:08, 17 December 2020 diff hist +7 Esophageal cancer →Regimen {{#subobject:d18acj2|Variant=1}}
- 00:52, 17 December 2020 diff hist +2,000 Esophageal cancer →Metastatic or locally advanced disease, first-line
- 15:54, 22 July 2020 diff hist 0 Esophageal cancer →Regimen {{#subobject:d1dde0|Variant=1}}
- 15:53, 22 July 2020 diff hist +48 m Esophageal cancer →Regimen {{#subobject:d1dde0|Variant=1}}
- 15:52, 22 July 2020 diff hist -18 m Esophageal cancer →Regimen {{#subobject:d1dde0|Variant=1}}